MedPath

A Scalp Lotion Toimprove Sensitive Scalp Syndrome

Completed
Conditions
Alopecia
Sensitive Skin
Registration Number
NCT05630027
Lead Sponsor
Cosmetique Active International
Brief Summary

Overall, 100 Caucasian subjects participated in this 6-weeks lasting study, AC5+ was applied daily. All subjects had clinically confirmed mild to moderate alopecia and self-declared sensitive scalp. Instrumental assessments included Trans Epidermal Water Loss (TEWL), inflammation markers, clinical assessments included the severity of erythema, inflammation and greasiness. Subjective/Self assessments comprised the intensity of the scalp itch/pruritus and the evaluation of their head hair status (volume, abundance, strength). Same assessments were provided by the investigators.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
100
Inclusion Criteria
  • >18 years
  • mild alopecia:
  • female: Ludwig type 1
  • male: Hamilton III to IV type
Exclusion Criteria
  • Moderate or severe alopecia
  • Dandruff

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
erythemaDay 21

on a scale from o=none to 5=severe

inflammationDay 21

on a scale from o=none to 5=severe

greasinessDay 21

on a scale from o=none to 5=severe

Global soothing scoreDay 21

sum of the symptoms with a score up to 15

Secondary Outcome Measures
NameTimeMethod
hair qualityDay 21

on a scale from o=none to 5=severe

Squalene monohydroperoxideDay 21

skin swabs analysis

pruritusDay 21

on a scale from o=none to 5=severe

burningDay 21

on a scale from o=none to 5=severe

Inflammation markersDay 21

skin swabs analysis skin swabs analysis

stingingDay 21

on a scale from o=none to 5=severe

scratchingDay 21

on a scale from o=none to 5=severe

Transepidermal water lossDay 21

instrumental measurements

squaleneDay 21

skin swabs analysis skin swabs analysis

Trial Locations

Locations (1)

L'OREAL Research and Innovation

🇫🇷

Saint-Ouen, France

© Copyright 2025. All Rights Reserved by MedPath